Question 1

What is the catalog number for TAT-AKAP79 (326-336) scrambled - (TAT Conjugated Peptides)?

Accepted Answer

The catalog number for TAT-AKAP79 (326-336) scrambled - (TAT Conjugated Peptides) is CRB1001278.

Question 2

What sizes are available for TAT-AKAP79 (326-336) scrambled - (TAT Conjugated Peptides)?

Accepted Answer

TAT-AKAP79 (326-336) scrambled - (TAT Conjugated Peptides) is available in the following size(s): 0.5 mg, 1 mg.

Question 3

How many pack sizes does TAT-AKAP79 (326-336) scrambled - (TAT Conjugated Peptides) come in?

Accepted Answer

TAT-AKAP79 (326-336) scrambled - (TAT Conjugated Peptides) is available in 2 different pack sizes.

Question 4

Is TAT-AKAP79 (326-336) scrambled - (TAT Conjugated Peptides) in stock?

Accepted Answer

TAT-AKAP79 (326-336) scrambled - (TAT Conjugated Peptides) is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

Do you offer custom or private-label production of this type of product?

Accepted Answer

Yes, custom antibody development and private-label production services are available. Contact our sales team to discuss your target, timeline, and quantity requirements.

Question 6

What is the immunogen used to generate this antibody?

Accepted Answer

Immunogen or antigen details used to raise this antibody are listed on the product datasheet under immunogen information.

Question 7

What is the recommended positive control for this assay?

Accepted Answer

A recommended positive control, where one is specified by the manufacturer, is listed on the datasheet or in the assay protocol.

TAT-AKAP79 (326-336) scrambled - (TAT Conjugated Peptides)

Product Specifications

Sequence

Available Sizes

Frequently Asked Questions

Explore Other Products

Thyroglobulin (TGB04 + TGB05), CF640R conjugate, 0.1mg/mL

CD34 (HPCA1/1171), CF488A conjugate, 0.1mg/mL

Cytokeratin, pan (Epithelial Marker) (KRTH/1576R + KRTL/1577R), CF488A conjugate, 0.1mg/mL

CD147 (BSG/963), 0.2mg/mL

CD56 / NCAM (123A8, same as 56C04), CF594 conjugate, 0.1mg/mL

RAD51 (Prognostic and Response to Chemotherapy Marker) (RAD51/2701), CF647 conjugate, 0.1mg/mL